<DOC>
	<DOCNO>NCT02385097</DOCNO>
	<brief_summary>This Study evaluate non-inferiority Test product ( Chloroprocaine 2 % ) versus Reference product ( Ropivacaine 0.75 % ) term proportion subject successful block distal upper limb surgery , without supplementation first 45 min ( see definition ) , calculated time readiness surgery ( complete sensory block ) . Successful block : anaesthesia adequate surgery ( complete sensory block ) , without supplementation first 45 min ( even surgery last &gt; 45 min ) , calculated time readiness surgery ( complete sensory block ) . Supplementation : i.v . premedication general anaesthesia pre- intra-operative systemic analgesia additional local anaesthetic infiltration</brief_summary>
	<brief_title>Chloroprocaine 2 % - Axillary Block</brief_title>
	<detailed_description />
	<mesh_term>Ropivacaine</mesh_term>
	<mesh_term>Chloroprocaine</mesh_term>
	<mesh_term>Procaine</mesh_term>
	<criteria>1 . Sex surgery : male female patient schedule short duration ( &lt; 60 min ) distal upper limb surgery axillary nerve block anaesthesia 2 . Age : â‰¥ 18 year old 3 . Body Mass Index ( BMI ) : 18 32 kg/m2 inclusive 4 . ASA physical status : IIII 5 . Informed consent : sign write informed consent inclusion study 6 . Full comprehension : ability comprehend full nature purpose study , include possible risk side effect ; ability cooperate investigator comply requirement entire study 1 . Physical finding : clinically significant abnormal physical finding could interfere objective study . Contraindications peripheral nerve block anaesthesia . History neuromuscular disease upper extremity 2 . Axillary status : Axillary local infection , surgical scar pathological lymph node enlargement 3 . ASA physical status : IVV 4 . Further anaesthesia : Patients anticipate require anaesthesia ( general local anaesthesia ) 5 . Chronic pain syndrome : Patients chronic pain syndrome ( take opioids , antidepressant , anticonvulsant agent ) 6 . Allergy : ascertain presumptive hypersensitivity active principle and/or formulation ingredient ; ascertain presumptive hypersensitivity amide estertype anaesthetic 7 . Diseases : significant history renal , hepatic , gastrointestinal , cardiovascular , respiratory , skin , haematological , endocrine neurological disease may interfere aim study ; ascertain psychiatric disease , sepsis , blood coagulation disorder , insulin dependent diabetes mellitus , terminal kidney failure 8 . Medications : Medication know interfere extent regional block ( see chloroprocaine ropivacaine SmPCs ) 2 week start study . Hormonal contraceptives female allow 9 . Investigative drug study : participation evaluation investigational product 3 month study , calculate first day month follow last visit previous study 10 . Drug , alcohol : history drug alcohol abuse 11 . Pregnancy : miss positive pregnancy test screening , pregnant lactating woman</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2016</verification_date>
</DOC>